About
In the firm's investment criteria and process, they are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology.
The focal point lies in supporting founders who possess a deep comprehension of the intricate network of healthcare system stakeholders, coupled with significant engineering innovation, advanced data science, and information technology-enabled solutions. Operating primarily from Europe, the firm aim is to identify and assist founders driven by genuine needs, committed to serving these stakeholders on a global scale with effectiveness and efficiency.
The firm invests broadly across Europe, including the United Kingdom, in the United States, Canada, Israel, and Australia, with a collaborative approach in how they work and interact with other players in their industry. Their goal is to help thoughtful and committed teams bridge the chasm from founding to series A capital and access global markets.
Portfolio
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Nina Capital's primary investment focus?
- Nina Capital primarily focuses on Health Tech & Life Sciences, as indicated by all of its portfolio companies and investment rounds being in this sector.
- When was Nina Capital founded?
- Nina Capital was founded in 2019.
- Which countries does Nina Capital invest in?
- Nina Capital invests broadly across Europe, including the United Kingdom, in the United States, Canada, Israel, and Australia.
- What is Nina Capital's investment strategy regarding healthcare technology?
- Nina Capital's investment criteria are informed by the Stanford-born Biodesign methodology, focusing on need-driven and value-based approaches to reinventing healthcare with technology. They support founders with deep comprehension of healthcare system stakeholders, significant engineering innovation, advanced data science, and IT-enabled solutions.
- What is the typical investment stage for Nina Capital?
- Nina Capital invests in Pre-Seed, Seed, and A Round stages. According to startupim data, they have made 2 Seed investments, 2 A Round investments, and 1 SAFE investment.
- Can you name some notable companies in Nina Capital's portfolio?
- Nina Capital's portfolio includes Chiefy, which raised $4.2M, and QuantHealth, which raised $21.01M. For a full list, please refer to startupim.
- Has Nina Capital closed any funds recently?
- Yes, Nina Capital closed an oversubscribed second fund in February 2022. They also launched a €40 million fund in June 2021.
- What is Nina Capital's approach to supporting portfolio companies?
- Nina Capital aims to help thoughtful and committed teams bridge the gap from founding to Series A capital and access global markets.
- What is Nina Capital's first recorded investment date?
- Nina Capital's first recorded investment date was October 1, 2022.